PerZeption Inc. Partners with Alcon Research to Advance Vision Correction Evaluation
PerZeption Inc. announces a collaboration with Alcon Research to enhance methods for evaluating vision correction. At the ARVO annual meeting, they will present data validating their AIM+ CSF modeling technology, which demonstrates rapid and sensitive assessment of contrast vision. The technology supports efficient detection of clinically meaningful visual differences, making it a valuable tool for objective visual performance evaluation.
BOSTON, MA, May. 1, 2026 /PRNewswire/ — Advancements in vision correction evaluation require methods that offer both precision and efficiency in detecting clinically meaningful visual differences. Addressing this need, PerZeption is set to present new data validating its AIM+ CSF…